1 min listen
Pharmacy Benefits and Disease-Modifying Therapies
FromNeurology Minute
ratings:
Length:
3 minutes
Released:
Feb 17, 2022
Format:
Podcast episode
Description
Dr. Daniel Hartung discusses the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis. Show references: https://cp.neurology.org/content/12/1/36 https://www.neurology.org/podcast
Released:
Feb 17, 2022
Format:
Podcast episode
Titles in the series (100)
Featured interview: MOG-IgG cell based assays: Featured interview: MOG-IgG cell based assays by Neurology Minute